Radius Health, Inc. provided net sales guidance for the year 2018. For the full year of 2018, the company expected it has exceeded its 2018 financial guidance with full-year TYMLOS® U.S. net sales surpassing the upper range of $95 million to $98 million. The company maintains its financial guidance for 2019 and expects full-year TYMLOS U.S. net sales to be between $155 million to $175 million.